Suppr超能文献

预防电休克治疗后发作期后灌注不足和认知副作用的药物:一项回顾性队列研究。

Medication preventing postictal hypoperfusion and cognitive side-effects in electroconvulsive therapy: A retrospective cohort study.

作者信息

Verdijk Joey P A J, Schuur Gijsbert, Pottkämper Julia C M, Ten Doesschate Freek, Hofmeijer Jeannette, van Waarde Jeroen A

机构信息

Department of Psychiatry, Rijnstate Hospital, Arnhem, Netherlands.

Department of Clinical Neurophysiology, TechMed Centre, University of Twente, Enschede, Netherlands.

出版信息

Front Psychiatry. 2023 Feb 9;14:1026014. doi: 10.3389/fpsyt.2023.1026014. eCollection 2023.

Abstract

BACKGROUND

Electroconvulsive therapy (ECT) is associated with postictal confusion and cognitive side-effects. In rats, acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs) and calcium antagonists decreased postictal cerebral hypoperfusion along with reduction in postictal symptoms. In this study, in ECT-patients, we explore associations between use of these potentially protective medications and occurrence of postictal confusion and cognitive outcome.

MATERIALS AND METHODS

In this retrospective, naturalistic cohort study, patient-, treatment-, and ECT-characteristics, were collected from medical files of patients treated with ECT for major depressive disorder (MDD) or bipolar depressive episode. To test for associations of use of these medications with occurrence of postictal confusion, 295 patients could be included. Cognitive outcome data were available in a subset of 109 patients. Univariate analyses and multivariate censored regression models were used to test for associations.

RESULTS

Occurrence of severe postictal confusion was not associated with use of acetaminophen, NSAIDs or calcium antagonists ( = 295). Regarding the cognitive outcome measure ( = 109), use of calcium antagonists was associated with higher post-ECT cognitive scores (i.e., better cognitive outcome; β = 2.23; = 0.047), adjusted for age (β = -0.02; = 0.23), sex (β = -0.21; = 0.73), pre-ECT cognitive score (β = 0.47; < 0.0001), and post-ECT depression score (β = -0.02; = 0.62), but use of acetaminophen (β = -1.55; = 0.07) as well as NSAIDs (β = -1.02; = 0.23) showed no associations.

CONCLUSION

This retrospective study does not find arguments for protective effects of acetaminophen, NSAIDs or calcium antagonists against severe postictal confusion in ECT. As a preliminary finding, the use of calcium antagonists was associated with improved cognitive outcome after ECT in this cohort. Prospective controlled studies are necessary.

摘要

背景

电休克疗法(ECT)与发作后意识模糊及认知副作用相关。在大鼠中,对乙酰氨基酚、非甾体抗炎药(NSAIDs)和钙拮抗剂可减少发作后脑灌注不足,并减轻发作后症状。在本研究中,我们对接受ECT治疗的患者进行探索,以研究使用这些具有潜在保护作用的药物与发作后意识模糊的发生及认知结果之间的关联。

材料与方法

在这项回顾性自然队列研究中,从接受ECT治疗的重度抑郁症(MDD)或双相抑郁发作患者的病历中收集患者、治疗及ECT相关特征。为检验这些药物的使用与发作后意识模糊发生之间的关联,纳入了295例患者。109例患者的子集可获得认知结果数据。采用单因素分析和多因素删失回归模型进行关联性检验。

结果

严重发作后意识模糊的发生与对乙酰氨基酚、NSAIDs或钙拮抗剂的使用无关(n = 295)。关于认知结果测量(n = 109),在对年龄(β = -0.02;P = 0.23)、性别(β = -0.21;P = 0.73)、ECT前认知评分(β = 0.47;P < 0.0001)和ECT后抑郁评分(β = -0. .02;P = 0.62)进行校正后,钙拮抗剂的使用与ECT后更高的认知评分相关(即更好的认知结果;β = 2.23;P = 0.047),但对乙酰氨基酚(β = -1.55;P = 0.07)以及NSAIDs(β = -1.02;P = 0.23)的使用未显示出相关性。

结论

这项回顾性研究未发现对乙酰氨基酚、NSAIDs或钙拮抗剂对ECT中严重发作后意识模糊具有保护作用的证据。作为一项初步发现,在该队列中,钙拮抗剂的使用与ECT后认知结果改善相关。有必要进行前瞻性对照研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d26/9947286/87e5116b55ed/fpsyt-14-1026014-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验